Internal Medicine, Gastroenterology · San Antonio, TX
NPI
1881699734
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 E Euclid Ave
San Antonio, TX, 78212
Phone (210) 271-0606
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
4,303 services
Medicare patients, 2024
533
Average age 73
Drug cost, 2024
$606K
3,060 prescriptions
Company payments, 2025
$1,364
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard L Otero was code 43239 (upper gi endoscopy), 189 times for 184 patients. In total Richard L Otero billed 4,303 services in 32 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 189 | 184 | $56.67 | $11K |
| 99213 Office E&M - Established | Office | 131 | 95 | $62.38 | $8,172 |
| 99214 Office E&M - Established | Office | 128 | 91 | $86.60 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 109 | 109 | $128.87 | $14K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 90 | 90 | $167.23 | $15K |
| 43249 Upper GI Endoscopy | Facility | 81 | 75 | $108.48 | $8,787 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 56 | 56 | $167.84 | $9,399 |
| 45385 Colonoscopy - Lesion Removal | Facility | 43 | 43 | $198.44 | $8,533 |
| 45378 Lower GI Endoscopy - Other | Facility | 25 | 25 | $116.66 | $2,916 |
| 99204 Office E&M - New | Office | 23 | 23 | $94.80 | $2,180 |
| 99212 Office E&M - Established | Office | 19 | 19 | $34.40 | $654 |
| 43235 Upper GI Endoscopy | Facility | 13 | 13 | $91.57 | $1,190 |
By year: 2022 $93K for 888 services; 2023 $112K for 1,818 services; 2024 $153K for 4,303 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard L Otero prescribed most often to Medicare patients was Omeprazole, with 594 prescriptions and refills. In total Richard L Otero wrote 3,060 Medicare prescriptions that cost $606K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 594 | 1,093 | 229 | $7,494 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 518 | 518 | 491 | $8,565 |
| Famotidine Generic | 499 | 872 | 168 | $7,235 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 235 | 235 | 228 | $32K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 183 | 183 | 172 | $3,222 |
| Pantoprazole Sodium Generic | 168 | 324 | 52 | $1,777 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 113 | 113 | 108 | $1,885 |
| Dicyclomine Hcl Generic | 77 | 90 | 26 | $1,037 |
| Linzess Linaclotide | 63 | 99 | 20 | $53K |
| Ondansetron Odt Ondansetron | 54 | 54 | 25 | $764 |
| Esomeprazole Magnesium Generic | 38 | 76 | Under 11 | $960 |
| Budesonide Dr Budesonide | 30 | 35 | Under 11 | $9,378 |
| Cholestyramine Cholestyramine (With Sugar) | 24 | 36 | Under 11 | $1,910 |
| Dexlansoprazole Dr Dexlansoprazole | 24 | 36 | Under 11 | $5,746 |
| Sucralfate Generic | 21 | 23 | Under 11 | $623 |
Brand drugs: 627 claims; generic drugs: 2,433 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard L Otero $1,364 ($1,364 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $464.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $464 |
| Janssen Biotech, Inc. JNJ | 21 | $440 |
| Echosens North America, Inc. | 1 | $108 |
| Lilly USA, LLC LLY | 4 | $80.09 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $73.73 |
| Gilead Sciences, Inc. GILD | 3 | $49.22 |
| Celltrion USA Inc. 068270.KS | 2 | $47.97 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $28.34 |
| Vivus LLC | 1 | $23.13 |
| Novo Nordisk Inc NVO | 1 | $20.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.